Mar 15, 2016 | blog, Cytocentric, Cytocentric-Blog
Cytocentric Visionaries: Michael Gilkey, CEO Trailhead Biosystems Part Two: How to Get that Just-Right Cell in the Middle Alicia Henn, Chief Scientific Officer, BioSpherix IIn the first part of our interview with Michael Gilkey, CEO of Trailhead Biosystems, we discuss...
Mar 15, 2016 | blog, Cytocentric, Cytocentric-Blog
Cytocentric Visionaries: Michael Gilkey, CEO Trailhead Biosystems Part One: Optimizing Cell Media in 12 Dimensions: You Can’t Do This by Hand Alicia Henn, Chief Scientific Officer, BioSpherix In addition to being CEO of the Ohio start-up Trailhead Biosystems,...
Mar 1, 2016 | blog, Cytocentric, Cytocentric-Blog
Cytocentric Visionaries: Donald Phinney Part 3: The Cell Cycle Is the Redox Cycle, and All Clinical MSC are Stressed In Part Two, Chief Scientific Officer Alicia Henn talked with Dr. Phinney about MSC, the exosomes that they produce and therapeutics. Today we...
Feb 26, 2016 | blog, Cytocentric, Cytocentric-Blog
Cytocentric Visionaries: Donald Phinney Part Two: MSC vs Exosomes and Therapies In Part One, Chief Scientific Officer Alicia Henn talks with Dr. Phinney about his publication in Nature Communications, ”Mesenchymal stem cells use extracellular vesicles to...
Feb 23, 2016 | blog, Cytocentric, Cytocentric-Blog
Cytocentric Visionaries: Donald Phinney, Chair Department of Molecular Therapeutics, The Scripps Research Institute Part One: Mesenchymal Stem Cells, as Healers, Aren’t So Selfless Chair of the Molecular Therapeutics Department at Scripps, Dr. Phinney has almost 20...
Recent Comments